4.1728
price up icon5.11%   0.2028
after-market Handel nachbörslich: 4.17 -0.0028 -0.07%
loading
Schlusskurs vom Vortag:
$3.97
Offen:
$3.98
24-Stunden-Volumen:
2,833
Relative Volume:
0.15
Marktkapitalisierung:
$74.62M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-12.63M
KGV:
-6.0109
EPS:
-0.6942
Netto-Cashflow:
$-12.18M
1W Leistung:
+2.27%
1M Leistung:
+15.59%
6M Leistung:
-9.87%
1J Leistung:
+20.15%
1-Tages-Spanne:
Value
$3.84
$4.1728
1-Wochen-Bereich:
Value
$3.82
$4.18
52-Wochen-Spanne:
Value
$2.79
$7.28

Genenta Science Spa Adr Stock (GNTA) Company Profile

Name
Firmenname
Genenta Science Spa Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
13
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
GNTA's Discussions on Twitter

Vergleichen Sie GNTA mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
GNTA
Genenta Science Spa Adr
4.1728 74.62M 0 -12.63M -12.18M -0.6942
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
500.19 127.64B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
603.58 65.95B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
656.65 37.92B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
273.55 32.98B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
254.16 26.92B 3.81B -644.79M -669.77M -6.24

Genenta Science Spa Adr Stock (GNTA) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2023-06-29 Fortgesetzt ROTH MKM Buy
2022-07-25 Eingeleitet H.C. Wainwright Buy
2022-01-13 Eingeleitet Maxim Group Buy

Genenta Science Spa Adr Aktie (GNTA) Neueste Nachrichten

pulisher
Apr 15, 2025

Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewswire Inc.

Apr 15, 2025
pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures €20M in mandatory convertible bond deal By Investing.com - Investing.com South Africa

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta secures $21.9 million for cancer drug trial - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Genenta Science Secures €20 Million Convertible Bond Financing for Oncology Research - TipRanks

Mar 19, 2025
pulisher
Jan 10, 2025

Genenta Science announces amendment to pact with AGC Biologics - Yahoo Finance

Jan 10, 2025
pulisher
Dec 30, 2024

Genenta Science Enhances Manufacturing Agreement with AGC Biologics - TipRanks

Dec 30, 2024
pulisher
Dec 20, 2024

Genenta Science Updates ATM Sales Agreement with New Agent - TipRanks

Dec 20, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading resumes - TipRanks

Nov 29, 2024
pulisher
Nov 29, 2024

Genenta Science SPA (ADR) trading halted, volatility trading pause - TipRanks

Nov 29, 2024
pulisher
Nov 13, 2024

3 US Penny Stocks With Market Caps Over $30M To Consider - Yahoo Finance

Nov 13, 2024
pulisher
Oct 23, 2024

Genenta Science CEO to present at U.S. Senate meeting - TipRanks

Oct 23, 2024
pulisher
Apr 02, 2024

Genenta Science Announces Shareholder Meeting - TipRanks

Apr 02, 2024
pulisher
Mar 26, 2024

symbol__ Stock Quote Price and Forecast - CNN

Mar 26, 2024
pulisher
Mar 04, 2024

DHR Stock Quote Price and Forecast - CNN

Mar 04, 2024

Finanzdaten der Genenta Science Spa Adr-Aktie (GNTA)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$72.58
price up icon 0.39%
$21.55
price up icon 0.33%
$33.00
price up icon 0.33%
$28.02
price up icon 0.43%
$101.10
price down icon 3.66%
biotechnology ONC
$254.16
price down icon 0.63%
Kapitalisierung:     |  Volumen (24h):